MPEC @MassGeneralNews is dedicated to improving clinical outcomes, increasing value in health policy, and informing public health through research and training
Dr. Ingrid Bassett received the inaugural Public Service Leave from the Harvard Impact Lab and is spending 8 months working part-time with the Massachusetts Department of Public Health. See a blog about her experience working on pediatric immunization here https://t.co/f1FbBNzWLl
A new study by @mgh_mpec investigators in @PubHealth_BMC found that HIV medication price accounts for 74% of projected HIV-related costs for youth with HIV
MGH investigators analyzed data from sexual health clinic sites in the Boston area and found that among those with #PrEP indications, young females were less likely to be prescribed PrEP compared with male peers and older females. @NeilanAnne
Led by researchers at @mgh_mpec and @OPHID_Trust, modeling analysis in @JIDJournal projects that long-acting injectable ART could prevent infant infections, improve maternal life expectancy and be cost-effective in Zimbabwe. #HIV#maternalandchildhealth
Dr. Ingrid Bassett was one of the recipients of the @ImpactatHarvard 's Paid Service Leaves. She will be working with @MassDPH to design and evaluate childhood vaccination outreach and communication strategies. Read more about the program at: https://t.co/LwDZdcmS3V
Just out in NEJM: Drs. Siedner, Gaziano, Magula & colleagues show substantially improved hypertension care in rural South Africa by transferring treatment from clinic to home w/BP machines for self-monitoring, CHW check-ins, and remote care by nurses with an mHealth app.
A new study in @AnnalsofIM found that participants with social risk factors at the time of SARS-CoV-2 infection had greater risk for subsequent long COVID than those without. Read more here: https://t.co/x8W8gjKzgS
Hyle et al. found that the WHO-recommended package for advanced HIV disease (AHD) would improve clinical outcomes and quality-adjusted life expectancy and be cost-effective in Malawi and is likely to be cost-effective in most high burden HIV settings.
These findings from the multi-disciplinary team at MGH, EGPAF, and the WHO underscore the substantial clinical and economic benefits of ensuring the availability and implementation of the WHO-recommended AHD package of care globally.